Breaking News Instant updates and real-time market news.

CLVS

Clovis

16:01
06/19/17
06/19
16:01
06/19/17
16:01

Clovis files to sell $250M in common stock

J. P. Morgan Securities LLC and BofA Merrill Lynch are acting as joint book-running managers for the offering. Stifel and SunTrust Robinson Humphrey are acting as co-managers for the offering. Clovis Oncology intends to use the net proceeds of the offering for general corporate purposes, including sales and marketing expenses associated with Rubraca in the United States and, if approved by the European Medicines Agency, in Europe, funding of its development programs, general and administrative expenses, acquisition or licensing of additional product candidates or businesses and working capital.

CLVS Clovis

06/19/17
JEFF
06/19/17
NO CHANGE
Target $124
JEFF
Hold
Tesaro worth $80 per share on fundamentals, says Jefferies
Jefferies analyst Eun Yang views Clovis Oncology's (CLVS) data today for rucaparib as "highly competitive" to Tesaro's (TSRO) niraparib. The data from Clovis will likely impact any potential takeover premium for Tesaro, Yang tells investors in a research note. The analyst views Tesaro as being worth $80 per share on a fundamental basis. She has a Hold rating and $124 price target on the shares. Tesaro in early trading is down 5%, or $7.09, to $137.22.
06/19/17
06/19/17
UPGRADE

On The Fly: Top five analyst upgrades
Catch up on today's top five analyst upgrades with this list compiled by The Fly: 1. Biogen (BIIB) upgraded to Neutral from Sell at UBS with analyst Carter Gould saying he sees an improved risk/reward and a positive near-term setup going into the second quarter earnings call and strategic review. 2. Clovis (CLVS) upgraded to Neutral from Sell at Chardan. 3. Cedar Fair (FUN) upgraded to Conviction Buy from Buy at Goldman Sachs with analyst Christopher Prykull saying early season indicators appear strong as several management teams noted ongoing leisure strength at the firm's Lodging, Gaming Restaurant and Leisure Conference. 4. Athene Holding (ATH) upgraded to Outperform from Neutral at Credit Suisse with analyst John Nadel saying he believes the probability is increasing that Athene will use acquisitions to accelerate its balance sheet and earnings growth. 5. Credit Suisse (CS) upgraded to Buy from Hold at Deutsche Bank with analyst Kinner Lakhani saying an inflection in the company's operating results is near following the recent anticipated capital raise. This list is just a portion of The Fly's full analyst coverage. To see The Fly's full Street Research coverage, click here.
06/19/17
COWN
06/19/17
NO CHANGE
Target $125
COWN
Market Perform
Tesaro price target cut to $125 from $145 at Cowen
Cowen analyst Boris Peaker reduced Tesaro's (TSRO) price target to $125 from $145 following Clovis' report this morning that rucaparib's pivotal ARIEL3 study met its PFS endpoint. The analyst said that all three leading PARPs are largely undifferentiated and trimmed niraparib peak rates across all subgroups. The analyst rates Tesaro shares a Market Perform.
06/19/17
LEER
06/19/17
NO CHANGE
Target $114
LEER
Outperform
Clovis price target raised to $114 from $85 at Leerink
Leerink analyst Michael Schmidt raised his price target for Clovis Oncology (CLVS) to $114 following this morning's top-line Phase III Ariel3 results for Rubraca. The analyst views the data as "very compelling" when compared to competitor PARP inhibitors in ovarian cancer. He expects Rubraca to obtain a broad label in the second line ovarian cancer maintenance setting. As stated earlier today, Schmidt believes Clovis now represents a "prime takeout candidate." The analyst, however, notes that his new price target does not incorporate a takeout valuation. Schmidt keeps an Outperform rating on Clovis.

TODAY'S FREE FLY STORIES

SUPN

Supernus

$49.65

0.6 (1.22%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Downgrade
Supernus rating change  »

Supernus downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

HSIC

Henry Schein

$80.90

-1.98 (-2.39%)

07:37
09/19/17
09/19
07:37
09/19/17
07:37
Initiation
Henry Schein initiated  »

Henry Schein initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

KMX

CarMax

$68.34

0.26 (0.38%)

07:36
09/19/17
09/19
07:36
09/19/17
07:36
Recommendations
CarMax analyst commentary  »

CarMax price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Sep

PTLA

Portola Pharmaceuticals

$56.57

1.62 (2.95%)

07:36
09/19/17
09/19
07:36
09/19/17
07:36
Periodicals
Portola blood thinner launch could be complicated by guidelines, STAT News says »

The commercial launch of…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Feb

CRL

Charles River

$107.29

1.27 (1.20%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Initiation
Charles River initiated  »

Charles River initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

POST

Post Holdings

$85.84

1.04 (1.23%)

, BOBE

Bob Evans

$72.93

1.02 (1.42%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Hot Stocks
Post Holdings to acquire Bob Evans for $77.00 per share »

Post Holdings (POST) and…

POST

Post Holdings

$85.84

1.04 (1.23%)

BOBE

Bob Evans

$72.93

1.02 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ABX

Barrick Gold

$16.92

-0.38 (-2.20%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Conference/Events
Barrick Gold management to meet with Deutsche Bank »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 26

    Oct

FB

Facebook

$170.01

-1.63 (-0.95%)

, AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Periodicals
FB design head touts voice command, stays silent on hardware, TechCrunch says »

Facebook (FB) head of…

FB

Facebook

$170.01

-1.63 (-0.95%)

AMZN

Amazon.com

$974.19

-12.6 (-1.28%)

GOOG

Alphabet

$915.00

-5.29 (-0.57%)

GOOGL

Alphabet Class A

$929.75

-5.54 (-0.59%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    Nov

OA

Orbital ATK

$132.25

22.21 (20.18%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Downgrade
Orbital ATK rating change  »

Orbital ATK downgraded to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NVDA

Nvidia

$187.55

7.44 (4.13%)

, FCX

Freeport McMoRan

$14.13

0.25 (1.80%)

07:35
09/19/17
09/19
07:35
09/19/17
07:35
Options
Unusual call flow in option market yesterday »

Notable call activity was…

NVDA

Nvidia

$187.55

7.44 (4.13%)

FCX

Freeport McMoRan

$14.13

0.25 (1.80%)

WFC

Wells Fargo

$52.71

1.05 (2.03%)

V

Visa

$104.83

-0.47 (-0.45%)

HIMX

Himax

$10.70

0.15 (1.42%)

COP

ConocoPhillips

$47.09

0.58 (1.25%)

STX

Seagate

$33.52

-0.03 (-0.09%)

MOS

Mosaic

$21.31

0.65 (3.15%)

TMUS

T-Mobile

$61.80

0.63 (1.03%)

FCAU

Fiat Chrysler

$16.82

0.16 (0.96%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Sep

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 12

    Oct

  • 29

    Nov

  • 15

    Jan

ESRX

Express Scripts

$62.01

-0.64 (-1.02%)

, ANTM

Anthem

$185.00

-1.59 (-0.85%)

07:34
09/19/17
09/19
07:34
09/19/17
07:34
Initiation
Express Scripts, Anthem initiated  »

Express Scripts initiated…

ESRX

Express Scripts

$62.01

-0.64 (-1.02%)

ANTM

Anthem

$185.00

-1.59 (-0.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

  • 25

    Oct

WBS

Webster Financial

$48.71

0.73 (1.52%)

07:33
09/19/17
09/19
07:33
09/19/17
07:33
Hot Stocks
Webster Financial announces CEO succession »

Webster Financial's…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    Nov

AAPL

Apple

$158.67

-1.21 (-0.76%)

07:32
09/19/17
09/19
07:32
09/19/17
07:32
Recommendations
Apple analyst commentary  »

Apple price target raised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TEVA

Teva

$16.99

-1.11 (-6.13%)

07:32
09/19/17
09/19
07:32
09/19/17
07:32
Hot Stocks
Teva completes amendment to credit facilities »

Teva Pharmaceutical…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

CTLT

Catalent

$39.90

0.41 (1.04%)

07:31
09/19/17
09/19
07:31
09/19/17
07:31
Hot Stocks
Catalent to acquire Cook Pharmica for $950M »

Catalent announced it has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MRTX

Mirati Therapeutics

$10.80

-0.4 (-3.57%)

07:31
09/19/17
09/19
07:31
09/19/17
07:31
Initiation
Mirati Therapeutics initiated  »

Mirati Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

POST

Post Holdings

$85.84

1.04 (1.23%)

, BOBE

Bob Evans

$72.93

1.02 (1.42%)

07:31
09/19/17
09/19
07:31
09/19/17
07:31
Hot Stocks
Breaking Hot Stocks news story on Post Holdings, Bob Evans »

Post Holdings to acquire…

POST

Post Holdings

$85.84

1.04 (1.23%)

BOBE

Bob Evans

$72.93

1.02 (1.42%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ITRI

Itron

$76.50

3.7 (5.08%)

, SSNI

Silver Spring

$16.10

3.1 (23.85%)

07:30
09/19/17
09/19
07:30
09/19/17
07:30
Downgrade
Itron, Silver Spring rating change  »

Itron downgraded to Hold…

ITRI

Itron

$76.50

3.7 (5.08%)

SSNI

Silver Spring

$16.10

3.1 (23.85%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BOBE

Bob Evans

$72.93

1.02 (1.42%)

07:30
09/19/17
09/19
07:30
09/19/17
07:30
Hot Stocks
Breaking Hot Stocks news story on Bob Evans »

Bob Evans trading halted,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

T

AT&T

$37.42

0.32 (0.86%)

, CRM

Salesforce

$95.74

1.11 (1.17%)

07:30
09/19/17
09/19
07:30
09/19/17
07:30
Options
Unusual put flow in option market yesterday »

Notable put activity was…

T

AT&T

$37.42

0.32 (0.86%)

CRM

Salesforce

$95.74

1.11 (1.17%)

AXON

Axovant Sciences

$22.88

1.54 (7.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 29

    Nov

Q

QuintilesIMS

$95.07

0.6 (0.64%)

07:29
09/19/17
09/19
07:29
09/19/17
07:29
Initiation
QuintilesIMS initiated  »

QuintilesIMS initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MTOR

Meritor

$24.35

1.77 (7.84%)

07:27
09/19/17
09/19
07:27
09/19/17
07:27
Recommendations
Meritor analyst commentary  »

Meritor price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

UAA

Under Armour

$17.37

-0.42 (-2.36%)

07:25
09/19/17
09/19
07:25
09/19/17
07:25
Technical Analysis
Technical View: Under Armour falls, analyst action »

The stock was last down…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    Oct

  • 04

    Oct

CAH

Cardinal Health

$67.07

-0.43 (-0.64%)

07:25
09/19/17
09/19
07:25
09/19/17
07:25
Initiation
Cardinal Health initiated  »

Cardinal Health initiated…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Sep

  • 22

    Sep

HAS

Hasbro

$93.24

-1.6 (-1.69%)

, MAT

Mattel

$14.87

-0.99 (-6.24%)

07:25
09/19/17
09/19
07:25
09/19/17
07:25
Hot Stocks
Toys"R"Us confirms filing Chapter 11 bankruptcy petitions in U.S. »

Toys"R"Us…

HAS

Hasbro

$93.24

-1.6 (-1.69%)

MAT

Mattel

$14.87

-0.99 (-6.24%)

JAKK

JAKKS Pacific

$2.85

-0.2 (-6.56%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.